Literature DB >> 28294358

Prevalence of Human Papillomavirus infection among Chilean women from 2012 to 2016.

Nicolás Vergara1, Gloria Espinoza2, Monserrat Balanda1, Andrea Quiero2, Wilma Hidalgo3, Héctor San Martín1, Alejandro Ramírez4, Eugenio Ramírez1,5.   

Abstract

Here, we evaluated the prevalence of Human Papillomavirus (HPV) in two groups of Chilean women. The first group consisted of 3235 women aged 18-64 years attended in six primary care centers of Santiago. The second group consisted of 456 women 18-85 aged who consulted the Gynaecology Department of the Reference Hospital of Santiago. Samples were collected from October 2012 to February 2016. Cervical swabs were analyzed both HPV genotyping by PCR and Reverse Line Blot, and cervical cytology by Pap testing. Results showed a prevalence of 12.0% HPV positive, 10.3% high-risk (HR) HPV types positive, 3.9% low-risk (LR) HPV types positive, and 1.0% Pap positive in group 1. The most frequent types were 16, 66, and 59, with a prevalence of 3.0%, 1.6%, and 1.5%, respectively. The prevalence were 71.9% HPV positive, 67.3% HR-HPV types positive, 13.6% LR-HPV types positive, and 62.5% Pap positive in group 2. The most frequent types were 16, 31, and 58, with prevalence of 33.6%, 10.5%, and 7.0%, respectively. Among infected women with HPV: 7.6% were infected with HPV16 or HPV18, 3.0% with HPV31, HPV33 or HPV45, and 6.7% with any other HR-HPV. These findings show great difference in HPV prevalence and types between primary care and reference center, and provide useful epidemiological information to assess the impact of HPV vaccination in the future.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Chilean women; genotypes; human papillomavirus; prevalence

Mesh:

Year:  2017        PMID: 28294358     DOI: 10.1002/jmv.24805

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

1.  Detection and genotyping of HPV in urine samples from Chilean women attending primary health care centers.

Authors:  Nicolás Vergara; Monserrat Balanda; Wilma Hidalgo; Héctor San Martín; Alexis Aceituno; Francisco Roldán; Tania Villalón; Melissa Hott; Gloria Espinoza; Andrea Quiero; María T Valenzuela; Eugenio Ramírez
Journal:  Med Microbiol Immunol       Date:  2017-12-14       Impact factor: 3.402

2.  Genetic variability of human papillomavirus type 66 L1 gene among women presenting for cervical cancer screening in Chile.

Authors:  Monserrat Balanda; Jorge Fernández; Nicolás Vergara; Constanza Campano; Loredana Arata; Héctor San Martín; Eugenio Ramírez
Journal:  Med Microbiol Immunol       Date:  2019-06-04       Impact factor: 3.402

3.  Attitudes towards Human Papilloma Virus Vaccination in the Latin American Andean Region.

Authors:  Oroma Nwanodi
Journal:  Healthcare (Basel)       Date:  2017-09-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.